Clout Of Drug Industry Seen In MD Residency Programs And In Health Reform

Main Category: Pharma Industry / Biotech Industry
Also Included In: Primary Care / General Practice;  Medical Students / Training
Article Date: 24 Feb 2010 - 5:00 PDT

Current ratings for:
'Clout Of Drug Industry Seen In MD Residency Programs And In Health Reform'

Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (2 votes)

News outlets report on the pharmaceutical industry's involvement in doctor training and its role in shaping the health care overhauls pending in Congress.

The New York Times: "More than half of the nation's medical residency programs to train doctors in internal medicine accepted financial support from the drug industry, even though three-fourths of the programs' directors said accepting the aid was 'not desirable,' a survey found. At issue are potential conflicts of interest as the residency programs ... train tens of thousands of new doctors at a point in their careers when they are beginning to prescribe drugs..." The study, published Monday online in the Archives of Internal Medicine, was "conducted in 2006 and 2007 [and] found that drug companies paid for educational materials like pocket guides in 83 percent of the programs that accepted support," as well as meals, office supplies and drug samples (Wilson, 2/22).

NPR's Fresh Air talks with Sunlight Foundation senior writer Paul Blumenthal about the "secret deal" between the Pharmaceutical Research and Manufacturers of America (PhRMA), the White House and members of Congress in which "the pharmaceutical industry pledged to reduce health care costs by $80 billion over 10 years." Blumenthal explains the Obama administration put "'the biggest lobby in Washington on the side of health care reform.' Meanwhile, the pharmaceutical industry got a guarantee that 'Congress would not legislate any cost-cutting measures that would make a dent in industry profits.'" An investigation revealed that "Congress and PhRMA met dozens of times to negotiate that deal" (Gross, 2/22).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Clout Of Drug Industry Seen In MD Residency Programs And In Health Reform." Medical News Today. MediLexicon, Intl., 24 Feb. 2010. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/180210.php>
APA
Kaiser. (2010, February 24). "Clout Of Drug Industry Seen In MD Residency Programs And In Health Reform." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/180210.php.

Please note: If no author information is provided, the source is cited instead.


Add Your Opinion On This Article

'Clout Of Drug Industry Seen In MD Residency Programs And In Health Reform'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »